- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03507361
Myocardial Damage and Music Study (MYDA-MUSIC)
April 2, 2019 updated by: Christian Pristipino, San Filippo Neri General Hospital
Heart Rate Variability-based Music for the Prevention of PCI-related Myocardial Injury
MYDA-MUSIC study is a randomized, double blind (operator and analyst) study performed in San Filippo Neri Hospital, Roma, Italy and in Di Venere Hospital, Bari, Italy.
The planned study duration is 12 months.
The objectives are to assess the effects of heart-rate-variability based music on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients.
443 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive music or dumb earphones.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
443
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christian Pristipino, MD
- Phone Number: 0633062504
- Email: pristipino.c@gmail.com
Study Locations
-
-
RM
-
Roma, RM, Italy, 00152
- Recruiting
- San Filippo Neri General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic stable angina scheduled to undergo a coronary angiography and ad-hoc angioplasty
Exclusion Criteria:
- Abnormal c-TnI level before angiography
- Participation in other clinical studies
- Patients with pacemakers or defibrillators
- High rate atrial fibrillation (baseline heart rate >99 bpm) at enrolment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: MUSIC
Music will be administered through a normal computer equipped with a technology (Sound-of-Soul) that translates the patient's heart rate variability (HRV) into sounds according to a digital computer music-library.
Music will start 10 minutes before and will end at the completion of the interventional procedure
|
Music is produced by Sound-of-Soul technology that translates HRV power frequency spectrum real-time into music.
The intervals between the heartbeats are detected in milliseconds and then transferred into a frequency spectrum.
Sound of Soul system gets wired into different band pass filters which are linked to the frequencies of the heart (i.e.
low frequency and high frequency).
Once the signal is detected and computed, the Sound of Soul system links it through a musical instrument digital interface (MIDI).
This interface transforms ECG data into music and sounds.
The audio production is performed using a virtual instrumentation technology with different music libraries.
For the puropose of this study, all patients will ear the same instrument (arp).
Once the instrument have been selected, the ECG gets recorded and in real-time the patient can hear a music obtained from his/her own HRV.
The investigator will control the volume and the different settings of the music.
|
NO_INTERVENTION: DUMB EARPHONES
Dumb earphones will be placed over patient's ears starting 10 minutes before and ending at the completion of the interventional procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of procedure-related myocardial injury
Time Frame: within 24 hours from interventional procedure
|
c-TnI concentration >99th percentile URL in at least 1/3 blood drawings
|
within 24 hours from interventional procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall satisfaction with the procedure
Time Frame: From 5 to 30 minutes after the interventional procedure
|
Self-evaluation test on an analogic visual scale (score range 1-10, higher stress for higher values)
|
From 5 to 30 minutes after the interventional procedure
|
Difference in Distress self-evaluation baseline and after the intervention
Time Frame: Baseline and from 5 to 30 minutes after the interventional procedure
|
Self-evaluation test on an analogic visual scale (score range 1-10, higher stress for higher values)
|
Baseline and from 5 to 30 minutes after the interventional procedure
|
Evaluation of pain experienced during the interventional procedure
Time Frame: Baseline and from 5 to 30 minutes after the interventional procedure
|
Self-evaluation test (score range 1-10, higher pain for higher values)
|
Baseline and from 5 to 30 minutes after the interventional procedure
|
Difference in Anxiety evaluation baseline and after the intervention
Time Frame: Baseline and from 5 to 30 minutes after the interventional procedure
|
State-Trait Anxiety Inventory (STAI) test - Y italian version (score range 20-80, the higher the score the more anxiety the patients has, 2 subscales)
|
Baseline and from 5 to 30 minutes after the interventional procedure
|
Questionnaire regarding a narrative report of the procedure
Time Frame: From 5 to 30 minutes after the interventional procedure
|
Categorical analysis evaluated with a dedicated software analysing unstructured written narration of the experience of their invasive procedure.
|
From 5 to 30 minutes after the interventional procedure
|
Changes in Mean Heart rate during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (recorded for 5 to 10 minutes)
|
Calculation of Mean HR (beats/minute) on ECG samples recorded for 5 to 10 minutes
|
Baseline and at 5 minutes intervals (recorded for 5 to 10 minutes)
|
Changes in RR during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of Mean RR interval (msec) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in SDNN during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of SDNN (msec) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in RMSSD during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of RMSSD (msec) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in pNN50 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of pNN50 (%) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in pNN20 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of pNN20 (%) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in pNN10 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of pNN10 (%) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in pNN05 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of pNN05 (%) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in SD1 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of SD1 (msec) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in SD2 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of SD2 (msec) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in SD1/SD2 during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of SD1/SD2 ratio (number) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in VB during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of VB (sec) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in Stress index during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of stress index (number) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in CV during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of CV (number) on 5 to 10 minutes duration ECG samples.
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Changes in Power of frequency domains during the procedure (Heart rate variability measure)
Time Frame: Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Calculation of the power of VLF, LF, HF and total frequency-domain power on 5 to 10 minutes duration ECG samples (ms2)
|
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
|
Postprocedural c-TnI peak concentration in patients undergoing coronary angioplasty
Time Frame: within 24 hours from interventional procedure
|
Highest concentration in c-TnI in 3 blood samples
|
within 24 hours from interventional procedure
|
Time-to-peak in c-TnI concentration in patients undergoing coronary angioplasty
Time Frame: within 24 hours from interventional procedure
|
Time-to-Highest concentration in c-TnI in 3 blood samples
|
within 24 hours from interventional procedure
|
Incidence of procedure-related myocardial infarction (myocardial infarction type 4a) in patients undergoing coronary angioplasty
Time Frame: within 24 hours from interventional procedure
|
c-TnI concentration >10 x the 99th percentile in at least 1/3 blood drawings
|
within 24 hours from interventional procedure
|
Incidence of in-hospital Major Adverse Cardiac Events in patients undergoing coronary angioplasty
Time Frame: Through study completion (average of 3 days)
|
Incidence of death, myocardial infarction, unplanned revascularization
|
Through study completion (average of 3 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 2, 2018
Primary Completion (ANTICIPATED)
May 1, 2021
Study Completion (ANTICIPATED)
December 1, 2021
Study Registration Dates
First Submitted
March 26, 2018
First Submitted That Met QC Criteria
April 24, 2018
First Posted (ACTUAL)
April 25, 2018
Study Record Updates
Last Update Posted (ACTUAL)
April 4, 2019
Last Update Submitted That Met QC Criteria
April 2, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- V1-Jan31-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Stable Angina
-
Fundação Educacional Serra dos ÓrgãosCompletedChronic Stable Angina PectorisBrazil
-
Benha UniversityCompletedChronic Stable Angina
-
Tasly Pharmaceuticals, Inc.RecruitingChronic Stable Angina PectorisUnited States
-
Neovasc Inc.Shockwave Medical, Inc.Active, not recruitingAngina Pectoris | Chronic Stable Angina | Angina Pectoris, StableNetherlands, Spain, United Kingdom, Germany, Italy, Switzerland, Belgium, France, Austria
-
Zhejiang Chinese Medical UniversityThe First Affiliated Hospital of Zhejiang Chinese Medical UniversityUnknownChronic Stable Angina PectorisChina
-
Zhejiang Chinese Medical UniversityThe Third Affiliated hospital of Zhejiang Chinese Medical University; The First...Unknown
-
Zhejiang Chinese Medical UniversityThe Third Affiliated hospital of Zhejiang Chinese Medical University; The First...UnknownChronic Stable Angina PectorisChina
-
Zhejiang Chinese Medical UniversityThe Third Affiliated hospital of Zhejiang Chinese Medical University; The First...UnknownChronic Stable Angina PectorisChina
-
Clinical Centre of SerbiaFondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyCompletedRefractory Angina | Chronic Stable AnginaSerbia
-
Roxane LaboratoriesCompletedHypertension | Vasospastic Angina | Chronic Stable AnginaUnited States
Clinical Trials on HRV-BASED MUSIC
-
University Hospital, Clermont-FerrandClinique cardio-pneumologique de Durtol; AlmerysCompletedMyocardial Infarction | Cardiac RehabilitationFrance
-
Universidad de AlmeriaCompleted
-
Ospedale di Circolo - Fondazione MacchiCompletedInfant Conditions | Infant Behavior | Infant MorbidityItaly
-
Chang Gung Memorial HospitalNational Science and Technology CouncilRecruitingPain, Postoperative | Shoulder PainTaiwan
-
Universidad Rey Juan CarlosGO fit Lab- IngesportCompleted
-
Oslo University HospitalUniversity of Oslo; University of Bergen; Norwegian Centre for Ageing and Health and other collaboratorsCompletedQuality of Life | Pain | Dementia | Music | Activity, MotorNorway
-
Dana-Farber Cancer InstituteCompletedStress | Anxiety | OncologyUnited States
-
ARCIM Institute Academic Research in Complementary...CompletedBurnout | Work-Related StressGermany
-
MetroHealth Medical CenterThe Cleveland Music School Settlement; Kulas FoundationCompleted
-
Northeastern UniversityRecruitingAlzheimer DiseaseUnited States